BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33538618)

  • 1. Similar clinical outcome of AMA immunoblot-M2-negative compared to immunoblot-positive subjects over six years of follow-up.
    Zandanell S; Strasser M; Feldman A; Strebinger G; Aigner G; Niederseer D; Laimer M; Mussnig B; Paulweber B; Datz C; Aigner E
    Postgrad Med; 2021 Apr; 133(3):291-298. PubMed ID: 33538618
    [No Abstract]   [Full Text] [Related]  

  • 2. Low rate of new-onset primary biliary cholangitis in a cohort of anti-mitochondrial antibody-positive subjects over six years of follow-up.
    Zandanell S; Strasser M; Feldman A; Tevini J; Strebinger G; Niederseer D; Pohla-Gubo G; Huber-Schönauer U; Ruhaltinger S; Paulweber B; Datz C; Felder TK; Aigner E
    J Intern Med; 2020 Apr; 287(4):395-404. PubMed ID: 31802567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial changes in enzyme inhibitory antibody to pyruvate dehydrogenase complex during the course of primary biliary cirrhosis.
    Hazama H; Omagari K; Masuda J; Kinoshita H; Ohba K; Sakimura K; Matsuo I; Isomoto H; Murase K; Murata I; Kohno S
    J Clin Lab Anal; 2000; 14(5):208-13. PubMed ID: 11018798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of newly developed ELISA using "MESACUP-2 test mitochondrial M2" kit for the diagnosis of primary biliary cirrhosis.
    Kadokawa Y; Omagari K; Hazama H; Ohba K; Masuda J; Kinoshita H; Hayashida K; Isomoto H; Mizuta Y; Murase K; Murata I; Kohno S
    Clin Biochem; 2003 May; 36(3):203-10. PubMed ID: 12726929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-mitochondrial antibodies detection assays for diagnosis of primary biliary cholangitis in southern Tunisia population.
    Mejdoub S; Hamza Z; Hachicha H; Chtourou L; Marrzouk S; Feki S; Jerbi A; Boukthir S; Bahloul Z; Tahri N; Masmoudi H
    Ann Biol Clin (Paris); 2022 Sep; 80(5):423-429. PubMed ID: 36453746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: is autoimmune cholangitis an early stage of primary biliary cirrhosis?
    Nakajima M; Shimizu H; Miyazaki A; Watanabe S; Kitami N; Sato N
    J Gastroenterol; 1999 Oct; 34(5):607-12. PubMed ID: 10535489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?
    Muratori P; Muratori L; Gershwin ME; Czaja AJ; Pappas G; MacCariello S; Granito A; Cassani F; Loria P; Lenzi M; Bianchi FB
    Clin Exp Immunol; 2004 Jan; 135(1):154-8. PubMed ID: 14678277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of indirect immunofluorescence test and immunoblot tests in the evaluation of antinuclear and antimitochondrial antibodies.
    Öztürk Ö; Dos Santos Duarte SD; Balaban HY; Şimşek H; Şener B
    Turk J Med Sci; 2022 Apr; 52(5):1697-1703. PubMed ID: 36422475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactivity to M2 proteins in antimitochondrial antibody-negative patients with primary biliary cirrhosis.
    Kitami N; Ishii H; Shimizu H; Adachi H; Komada T; Mikami H; Yokoi Y; Sato N
    J Gastroenterol Hepatol; 1994; 9(1):7-12. PubMed ID: 8155871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
    Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
    Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum reactivity against bacterial pyruvate dehydrogenase: increasing the specificity of anti-mitochondrial antibodies for the diagnosis of primary biliary cirrhosis.
    Miyakawa H; Tanaka A; Selmi C; Hosoya N; Mataki N; Kikuchi K; Kato T; Arai J; Goto T; Gershwin ME
    Clin Dev Immunol; 2006; 13(2-4):289-94. PubMed ID: 17162370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic significance of autoantibodies in patients with primary biliary cirrhosis].
    Xiao H; Chen JW; Xie X; Liu YM; Li F
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):209-14. PubMed ID: 22516989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern China.
    Liu H; Liu Y; Wang L; Xu D; Lin B; Zhong R; Gong S; Podda M; Invernizzi P
    BMC Gastroenterol; 2010 Sep; 10():100. PubMed ID: 20815889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological study of anti-M2 in antimitochondrial antibody-negative primary biliary cirrhosis.
    Kitami N; Komada T; Ishii H; Shimizu H; Adachi H; Yamaguchi Y; Kitamura T; Oide H; Miyazaki A; Ishikawa M
    Intern Med; 1995 Jun; 34(6):496-501. PubMed ID: 7549131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis.
    Han E; Jo SJ; Lee H; Choi AR; Lim J; Jung ES; Oh EJ
    Clin Chim Acta; 2017 Jan; 464():113-117. PubMed ID: 27864100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of positive immunoblotting but negative immunofluorescence for antimitochondrial antibodies in patients with liver diseases other than primary biliary cirrhosis.
    Masuda J; Omagar K; Miyakawa H; Hazama H; Ohba K; Kinoshita H; Matsuo I; Isomoto H; Murata I; Kohno S
    Autoimmunity; 2002 Mar; 35(2):135-41. PubMed ID: 12071436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature.
    Bizzaro N; Covini G; Rosina F; Muratori P; Tonutti E; Villalta D; Pesente F; Alessio MG; Tampoia M; Antico A; Platzgummer S; Porcelli B; Terzuoli L; Liguori M; Bassetti D; Brusca I; Almasio PL; Tarantino G; Bonaguri C; Agostinis P; Bredi E; Tozzoli R; Invernizzi P; Selmi C
    Clin Rev Allergy Immunol; 2012 Jun; 42(3):288-97. PubMed ID: 21188646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis.
    Gabeta S; Norman GL; Liaskos C; Papamichalis PA; Zografos T; Garagounis A; Rigopoulou EI; Dalekos GN
    J Clin Immunol; 2007 Jul; 27(4):378-87. PubMed ID: 17514501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Positive rate of anti-mitochondrial antibody in Japanese corporate workers].
    Koizumi H; Onozuka Y; Shibata M; Sano K; Ooshima Y; Morizane T; Ueno Y
    Rinsho Byori; 2000 Oct; 48(10):966-70. PubMed ID: 11215112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic value of anti-mitochondrial antibodies, especially in primary biliary cirrhosis.
    Tanaka A; Miyakawa H; Luketic VA; Kaplan M; Storch WB; Gershwin ME
    Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):295-9. PubMed ID: 12030434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.